ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB370

ECONomical STRIP Validation for CKD Screening: A Cross-Sectional Trial (ECON-STRIP)

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Bunyawannukul, Issaree, Khon Kaen University Faculty of Medicine, Khon Kaen, Thailand
  • Anutrakulchai, Sirirat, Khon Kaen University Faculty of Medicine, Khon Kaen, Thailand
  • Cha'on, Ubon, Khon Kaen University Faculty of Medicine, Khon Kaen, Thailand
  • Ophascharoensuk, Vuddhidej, Chiang Mai University Faculty of Medicine, Chiang Mai, Thailand
  • Kaewsanga, Yosapan, Khon Kaen University Faculty of Medicine, Khon Kaen, Thailand
Background

Chronic kidney disease (CKD) represents a significant global public health concern, particularly in low- and middle-income countries, where more than 80% of stage 3 CKD cases remain undiagnosed due to the limited availability of effective screening tools. The urine albumin-to-creatinine ratio (UACR) is the reference standard for detecting albuminuria; however, point-of-care dipstick tests offer a feasible and cost-effective alternative in resource-constrained settings.

Methods

This cross-sectional diagnostic study was conducted at Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Thailand. Random midstream spot urine samples were evaluated using seven testing methods: 1) MicroalbuPHAN® (manual visual strip), 2)
MicroalbuPHAN® with LAURA automated reader, 3) CYBOW 2 (manual visual strip), 4)
CYBOW 2 with automated reader, 5) Thai-developed AL strip using competitive immunochromatography, 6) standard macro-protein dipstick, and 7) UACR measured by the Roche® analyzer (reference standard).

Results

A total of 459 participants were enrolled, with a mean age of 62.42 ± 12.14 years and 52.72% being male. The prevalence of comorbidities included diabetes mellitus (61.44%), hypertension (60.57%), and CKD (34.20%). The mean estimated glomerular filtration rate (eGFR) was 68.52 ± 23.18 mL/min/1.73 m2, and the median UACR was 14.0 (IQR 4.54–80.79) mg/gCr. The lowest cost per test was observed with the macro-albumin strip, while the AL strip had the highest cost. Diagnostic performance for detecting UACR ≥ 30 mg/gCr varied across methods, with the highest receiver operating characteristic (ROC) area observed in strips coupled with automated readers. The strongest correlation with UACR was noted in the MicroalbuPHAN® with LAURA automated reader (r = 0.76), which also offered favorable economic value.

Conclusion

Semi-quantitative urine dipstick tests, especially when used with automated readers, demonstrate diagnostic performance comparable to laboratory-based UACR assessments at a reduced cost. These findings support the utility of such methods in CKD screening programs within resource-limited settings. Further studies incorporating clinical outcomes are recommended to validate their long-term efficacy.

Digital Object Identifier (DOI)